Evaluating cell lines as tumour models by comparison of genomic profiles.
about
Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical researchMouse Models in Prostate Cancer Translational Research: From Xenograft to PDXCulturing Uveal Melanoma CellsGenomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersIn Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right PlatformLeveraging big data to transform target selection and drug discoveryCancer stem cell targeted therapy: progress amid controversies.Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerCancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer MedicineTumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerKRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.Choosing the right cell line for renal cell cancer researchUsing Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyProteomics of ovarian cancer: functional insights and clinical applicationsPrioritizing therapeutic targets using patient-derived xenograft modelsCorrelation of an epigenetic mitotic clock with cancer riskMAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasOvarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerNutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasCisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian TumorsCulture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer MedicineA survey of current trends in computational drug repositioningOGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell linesIntegrated genetic and pharmacologic interrogation of rare cancersT-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerLayer-by-layer assembled fluorescent probes in the second near-infrared window for systemic delivery and detection of ovarian cancerRelating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational researchHow Consistent are Publicly Reported Cytotoxicity Data? Large-Scale Statistical Analysis of the Concordance of Public Independent Cytotoxicity Measurements.Optimization of cell lines as tumour models by integrating multi-omics data.Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.Drug Intervention Response Predictions with PARADIGM (DIRPP) identifies drug resistant cancer cell lines and pathway mechanisms of resistance.Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cellsAdipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 PathwayPaclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerModeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line.
P2860
Q50432263-06F3B9EC-856A-4E47-AE61-F3235B4F4DC5Q54604004-55386745-979A-4F2E-B492-086E21A55ACDQ54606559-DFED7091-DD11-4270-967D-8CEB2096821CQ54808585-1A10859E-AA8D-4C4F-86BA-00455DF5151AQ54808586-11339884-FD5C-4DAB-B30C-D5CDD5F8B4A2Q54814140-037F4BAC-3FFF-4DF7-A599-CBC8733AC665Q54814339-F146944C-AD18-48CA-B4E3-695AF775AEC0Q54814342-09743D6C-D4E2-43C9-8AFE-3508A77AE152Q54814346-EA640982-DA02-4686-966D-1A55E36B324EQ54814347-286FA977-27FE-44DF-AB90-E07DAA4096DAQ54814357-A831F539-909D-4CD8-8D0D-5AE845E4B907Q54832065-6382F48F-0BB0-4AEC-A2A4-AB2C3298ABFCQ54832067-648A8510-7522-4889-8B22-10B4343DC1C1Q54832435-E0FE34CD-0260-48D1-8CEE-CB35104748A0Q54835245-476EB8A4-53AF-4378-9FDD-D1E0234ED204Q54883213-D16A7670-28BE-4542-ADCE-709176E92119Q54895764-AEA3BC0B-B9C3-4B8C-B1DD-4CCD42094DD5Q54897382-518205FC-CE59-4154-ABE7-6FAACD994F61Q54898648-2D05D502-5FC8-42CD-88A7-8AF34DB8B056Q54898653-85632F55-899F-454A-9916-EC2B41269A51Q54898655-74E83F46-EACA-400C-9487-EE03F807BB33Q54898657-889F5F8C-4B25-4FE5-933D-F77AF6F56CB3Q54898659-D4CF5921-F51D-4F1A-8676-B318ADAF4A79Q54900722-2EDAF9C4-77E5-4EE6-8096-F853B76A81A1Q54904241-9A3923AA-E3DE-4747-B0E5-706C76C613C9Q54931684-9667E529-886E-49D0-8F32-606C5299EC29Q54931685-3CD80491-E2F5-4865-9566-616491A627A8Q54931703-9CB9846F-3C03-4181-A463-B03DB68F5160Q54936399-2E6F8A0E-3C5A-4FB1-A80C-2C16EE3AFFE1Q54936833-0D1F8699-4270-42C6-BF53-33D6A88E2A64Q54936898-25A125AA-71ED-4D37-ACD6-86A9C6FC7AEFQ54937005-DB07C7C4-9677-42F3-9E33-035BEBFB3F2CQ54937010-C09FCF6E-8CFB-4770-BE06-0DCF7F5D1CFBQ54937014-51B82103-052A-4AE2-A1D2-6E6E4D25B6A3Q54937026-854B3059-23E3-4A0F-AB6E-C31247A7B48EQ54937028-7503F30C-D525-45C9-87F6-2997951AB4A4Q54937030-A0250FD0-90CA-4562-AD1D-4AC4EFA22752Q54937031-283E87BA-FAA1-41AE-B924-A0F458D414F7Q54937035-F3E6A432-B1B7-4108-9EAF-1493891694AFQ54937039-8D2EE5E2-FD62-4BA1-9C67-63E8EC03785F
P1343
Q24289253-9708A0C5-9E0F-4534-92F1-98D6F2661733Q26746524-3DB76D7D-86C1-4253-BA48-DE3FAFABB0BCQ26750415-F8BD793D-FFDB-4025-B4CE-668B3751916CQ26751068-8EC6D7DC-BBD0-49FD-9A1B-2083E7D45C84Q26767210-BA82432A-FF4C-4EFC-A00F-EDB12D42BF7CQ26776403-D58A5E87-8699-4ECF-947D-A587B090B53FQ26779931-39C7027C-46B2-45D0-A2A9-22E3AB2BB082Q26780387-5AFF7D39-EA5B-4895-8C77-DFB258755142Q26800337-3EC85AFA-4AE0-4179-B3C4-B4ABE427B055Q26801410-C7528DCE-FCCE-4FEC-BB2C-502FCB9AA0D4Q26829125-3053EF60-00B7-48F3-939D-288F4B85E007Q27028117-97207EC6-9053-4B80-9DF3-67C512D30850Q27853164-286DD480-A151-4214-B095-3102A4C94B77Q28073283-F42CFA2A-326E-4C6B-B386-C7413AF6CBB8Q28076097-3FCBCC29-14E0-4291-9382-AB8B7B4A7D2EQ28082632-76B874ED-0F72-4249-B66F-5754D0750A16Q28083993-1883EA43-1A00-4B78-8380-B2B1E54B83D3Q28390569-49954C50-20F7-4512-9934-398377AF4CB8Q28393224-2CBFE0F6-BB49-4113-8F63-72C9968CA06EQ28543021-3B0E6D1D-BD54-42F1-A188-CAF02EEF7FCFQ28543351-B5C8594F-055F-469D-8555-CCC85E14A509Q28547093-908CB829-7EF8-4B9E-BC46-DAB3EDBE0134Q28550863-9356B6D3-838B-4BD5-849A-8431378F4160Q28553627-AF712C4B-8486-4EA6-ABC4-E51F02EC11FCQ28602324-26BF25BC-09A1-4B2F-B7F1-52F9D68185F9Q28818119-EEE5DFA5-DC81-42B9-A8F6-3DF9F92AEA8AQ28829289-D011FB1F-C375-437A-91BA-087B4706AD6CQ30277635-1C36048C-DD58-4383-9CC2-D781D4D55C14Q30409503-1F4F7CE3-90B6-43B3-B40A-52B1C97CA3ECQ30757601-CB7A57C0-F5E7-4274-B1CC-75C6FE047CD0Q30965534-696B2A63-6D7F-4A06-B5D4-85122D2845B3Q31018677-440F9974-84C7-4BEA-B32A-4F71345791D3Q31134293-E63A4AFB-FDA8-47EF-A4E1-363FB071D49BQ33431526-DFEBB3D9-B1C4-4894-922A-A6B1762AF8E8Q33556468-538391EE-3EFA-4324-BF98-3D02FC22815FQ33566765-24DE129A-DBA4-435F-9776-B3BC05AAD434Q33584044-E5C749D5-DB91-4AED-B401-E90CFB4E5A1AQ33586121-9B86543B-4CA3-40C8-9441-069FB49C621EQ33641924-6892A9C9-DAA9-4575-BF47-6F31A0EBB79EQ33655175-AAA61611-7D57-4909-9ECB-DC17C9B20EA1
P2860
Evaluating cell lines as tumour models by comparison of genomic profiles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluating cell lines as tumour models by comparison of genomic profiles.
@en
Evaluating cell lines as tumour models by comparison of genomic profiles.
@nl
type
label
Evaluating cell lines as tumour models by comparison of genomic profiles.
@en
Evaluating cell lines as tumour models by comparison of genomic profiles.
@nl
prefLabel
Evaluating cell lines as tumour models by comparison of genomic profiles.
@en
Evaluating cell lines as tumour models by comparison of genomic profiles.
@nl
P2860
P4510
P50
P356
P1476
Evaluating cell lines as tumour models by comparison of genomic profiles.
@en
P2093
Chris Sander
Douglas A Levine
P2860
P2888
P356
10.1038/NCOMMS3126
P407
P577
2013-01-01T00:00:00Z